News: Infectious Diseases

Ken Keiler studies basic molecular biology with the aim of developing new antibiotics.

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.

Public health officials and researchers gathered this month for a gamified version of an outbreak investigation.

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

The International Vaccine Institutes Bioscience Park MahnHoon Award recognizes his role in the development of several vaccines.

An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.

Yi Lu and Lauren Ehrlich of the College of Natural Sciences are among the cancer researchers with exciting projects on the horizon.